SCHEMBL26029079

SCHEMBL26029079

CC(F)(F)C(=O)OC(=O)C12CC3CC(C1)C1(OCC(COC(=O)C45CC6CC(CC(O)(C6)C4)C5)(COC(=O)C45CC6CC(CC(O)(C6)C4)C5)CO1)C(C3)C2

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
ABL1 P00519 1/20 0.39
TSHR P16473 1/20 0.39
RIN1 Q13671 1/20 0.39
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
USP2 O75604 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
POLB P06746 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ATM Q13315 1/20 0.32
HSD11B1 P28845 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26029076 0.92 ALDH1A1 (0.36) ALDH1A1TSHRNPC1RAB9ANPSR1
SCHEMBL17548714 0.89 ALDH1A1 (0.41) ALDH1A1ABL1TSHRRIN1NPC1
SCHEMBL17548712 0.88 ALDH1A1 (0.39) ALDH1A1ABL1TSHRRIN1NPC1
SCHEMBL19601040 0.87 ALDH1A1 (0.43) ALDH1A1ABL1TSHRRIN1NPC1
SCHEMBL26029074 0.86 ALDH1A1 (0.38) ALDH1A1ABL1TSHRRIN1NPC1
SCHEMBL26029077 0.84 MEN1 (0.32) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL26061892 0.83 ALDH1A1 (0.46) ALDH1A1ABL1TSHRRIN1NPC1
SCHEMBL17550517 0.83 ALDH1A1 (0.39) ALDH1A1ABL1TSHRRIN1NPC1
SCHEMBL19601036 0.82 ALDH1A1 (0.41) ALDH1A1ABL1TSHRRIN1NPC1
SCHEMBL19599762 0.82 MEN1 (0.32) ALDH1A1MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11740555-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11740555-B2 Resist composition and method for producing resist pattern RER1, GAR1, REV1 ALDH1A1 356/4885ABL1 2051/4885TSHR 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.